Leap Therapeutics, Inc. - stock earnings
LPTX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -12.5 million USD | 634000 USD |
| 2023Q3 | -13.7 million USD | ? USD |
| 2023Q2 | -13.4 million USD | ? USD |
| 2023Q1 | -41.0 million USD | ? USD |
| 2022Q4 | -12.1 million USD | ? USD |
| 2022Q3 | -15.9 million USD | ? USD |
| 2022Q2 | -17.8 million USD | ? USD |
| 2022Q1 | -10.1 million USD | ? USD |
| 2021Q4 | -10.8 million USD | 375000 USD |
| 2021Q3 | -11.1 million USD | 375000 USD |
| 2021Q2 | -9.5 million USD | 375000 USD |
| 2021Q1 | -9.1 million USD | 375000 USD |
| 2020Q4 | -6.7 million USD | 375000 USD |
| 2020Q3 | -7.1 million USD | 375000 USD |
| 2020Q2 | -6.5 million USD | 375000 USD |
| 2020Q1 | -7.2 million USD | 375000 USD |
| 2019Q4 | -8.0 million USD | ? USD |
| 2019Q3 | -7.9 million USD | ? USD |
| 2019Q2 | -8.4 million USD | ? USD |
| 2019Q1 | 1.5 million USD | ? USD |
| 2018Q4 | 1.5 million USD | ? USD |
| 2018Q3 | -6.6 million USD | ? USD |
| 2018Q2 | -7.4 million USD | ? USD |
| 2018Q1 | -10.6 million USD | ? USD |
| 2017Q4 | -6.6 million USD | ? USD |
| 2017Q3 | -6.8 million USD | ? USD |
| 2017Q2 | -6.9 million USD | ? USD |
| 2017Q1 | -9.4 million USD | ? USD |
| 2016Q4 | -5.7 million USD | ? USD |
| 2016Q3 | -7.3 million USD | ? USD |
| 2016Q2 | -7.5 million USD | ? USD |
| 2016Q1 | -5.1 million USD | ? USD |
| 2015Q4 | -1.7 million USD | ? USD |
| 2015Q3 | -5.8 million USD | ? USD |
| 2015Q2 | -6.7 million USD | ? USD |
| 2015Q1 | -6.9 million USD | ? USD |
| 2014Q4 | -7.6 million USD | ? USD |
| 2014Q3 | -10.1 million USD | ? USD |
| 2014Q2 | -4.4 million USD | ? USD |
| 2014Q1 | -3.4 million USD | ? USD |
| 2013Q4 | -3.9 million USD | ? USD |
| 2013Q3 | -10.2 million USD | ? USD |
| 2013Q2 | -2.4 million USD | ? USD |
| 2013Q1 | -1.9 million USD | ? USD |
LPTX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -81.4 million USD | ? USD |
| 2022 | -54.6 million USD | 375000 USD |
| 2021 | -40.6 million USD | 1.5 million USD |
| 2020 | -27.5 million USD | 1.5 million USD |
| 2019 | -32.9 million USD | 375000 USD |
| 2018 | -23.1 million USD | ? USD |
| 2017 | -29.7 million USD | ? USD |
| 2016 | -25.6 million USD | ? USD |
| 2015 | -21.1 million USD | ? USD |
| 2014 | -25.5 million USD | ? USD |
| 2013 | -18.3 million USD | ? USD |
| 2012 | -7.8 million USD | ? USD |
LPTX
Price: $3.22
52 week price:
Earnings Per Share: -3.98 USD
P/E Ratio: -0.73
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 72793
Ebitda: -6.8 millionMarket Capitalization: 65.0 million